Director dealings: Astrazeneca CEO raises stake

(Sharecast News) - Astrazeneca revealed on Friday that chief executive Pascal Soriot had acquired 60,000 ordinary shares in the FTSE 100-listed drugmaker. Soriot, who took over as CEO in October 2012, purchased the shares at an average price of 12,102p each, for a total value of £7.26m.

As of 1540 BST, Astrazeneca shares were up 0.82% at 12,530p.





Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Astrazeneca (AZN) Director name: Soriot,Pascal Amount purchased: 60,000 @ 12,102.00p Value: £7,261,199.80

Trustpilot Group (TRST) Director name: Roy ,Marcus Amount purchased: 45,436 @ 218.98p Value: £99,493.93

Trustpilot Group (TRST) Director name: Byng-Thorne,Zillah Amount purchased: 27,746 @ 215.14p Value: £59,692.75

Trustpilot Group (TRST) Director name: Byng-Thorne,Zillah Amount purchased: 17,854 @ 222.87p Value: £39,791.21

Tmt Investments (TMT) Director name: Selegenev,Alexander Amount purchased: 10,000 @ $3.23 Value: $32,300.00

Tmt Investments (TMT) Director name: Selegenev,Alexander Amount purchased: 3,000 @ $3.46 Value: $10,380.00

Domino's Pizza Group (DOM) Director name: Perriss,Robyn Amount purchased: 4,850 @ 204.50p Value: £9,918.40

Top Director Sells